Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Ipsen

Capitalization 12.61B 14.48B 11.42B 10.89B 19.82B 1,337B 20.54B 136B 53.92B 639B 54.33B 53.19B 2,307B P/E ratio 2026 *
15.2x
P/E ratio 2027 * 14.8x
Enterprise value 11.07B 12.71B 10.03B 9.57B 17.4B 1,174B 18.04B 119B 47.35B 562B 47.72B 46.71B 2,026B EV / Sales 2026 *
2.67x
EV / Sales 2027 * 2.37x
Free-Float
41.56%
Yield 2026 *
0.93%
Yield 2027 * 0.94%
1 day+1.82%
1 week-0.45%
Current month-5.27%
1 month+0.51%
3 months+30.22%
6 months+35.53%
Current year+31.43%
1 week 151.9
Extreme 151.9
157.6
1 month 151.9
Extreme 151.9
167.1
Current year 116
Extreme 116
167.1
1 year 87.95
Extreme 87.95
167.1
3 years 87.95
Extreme 87.95
167.1
5 years 66.55
Extreme 66.55
167.1
10 years 34.2
Extreme 34.2
167.1
Manager TitleAgeSince
Chief Executive Officer 59 2020-06-30
Chief Executive Officer 56 2019-12-31
Chief Tech/Sci/R&D Officer 59 2023-09-21
Director TitleAgeSince
Director/Board Member 61 2005-08-29
Chairman 68 2010-11-21
Director/Board Member 69 2012-05-31
Change 5d. change 1-year change 3-years change Capi.($)
+1.82%-0.45%+40.77%+50.67% 14.48B
-4.81%-6.11%+13.99%+185.61% 884B
-0.80%-1.15%+47.94%+58.09% 586B
+0.15%-2.19%+3.52%+43.97% 392B
+0.59%-3.25%+4.24%+23.90% 326B
+0.19%-1.87%+20.80%+32.98% 296B
+0.42%-0.10%+23.61%+59.86% 294B
+0.52%-0.88%+22.44%+11.49% 285B
-1.56%-3.66%+14.03%+57.39% 197B
-0.59%-2.91%+28.48%+86.56% 180B
Average -0.40%-1.66%+21.98%+61.05% 345.49B
Weighted average by Cap. -1.32%-1.67%+20.61%+81.44%

Financials

2026 *2027 *
Net sales 4.15B 4.76B 3.76B 3.59B 6.52B 440B 6.76B 44.65B 17.74B 210B 17.88B 17.5B 759B 4.32B 4.96B 3.91B 3.73B 6.78B 458B 7.03B 46.45B 18.46B 219B 18.6B 18.21B 790B
Net income 851M 977M 771M 735M 1.34B 90.24B 1.39B 9.16B 3.64B 43.18B 3.67B 3.59B 156B 856M 983M 775M 739M 1.34B 90.72B 1.39B 9.21B 3.66B 43.4B 3.69B 3.61B 157B
Net Debt -1.54B -1.76B -1.39B -1.33B -2.41B -163B -2.5B -16.52B -6.57B -77.88B -6.62B -6.48B -281B -2.36B -2.71B -2.14B -2.04B -3.71B -251B -3.85B -25.43B -10.11B -120B -10.18B -9.97B -432B
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
26-03-17 156.40 +1.82% 20,460
26-03-16 153.60 +0.85% 69,329
26-03-13 152.30 -0.65% 83,494
26-03-12 153.30 -1.86% 105,267
26-03-11 156.20 -0.57% 98,151
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
153.60EUR
Average target price
151.00EUR
Spread / Average Target
-1.69%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW